CD8A and neoplasm: Although we did not make discreet measurements of the absolute number of OVA257 specific CD8+ T-cells in the brain after TMEV-L/OVA treatment, our data show that there was an increase in the quantity and density of antigen specific T-cells inside the tumor, a more promising indicator of a positive therapeutic effect [38].